Northern Trust’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Sell |
357,178
-6,254
| -2% | -$253K | ﹤0.01% | 1848 |
|
|
2025
Q1 | $18.7M | Buy |
363,432
+5,816
| +2% | +$299K | ﹤0.01% | 1674 |
|
|
2024
Q4 | $19.8M | Buy |
357,616
+40,061
| +13% | +$2.22M | ﹤0.01% | 1692 |
|
|
2024
Q3 | $10.4M | Buy |
317,555
+64,539
| +26% | +$2.12M | ﹤0.01% | 2043 |
|
|
2024
Q2 | $6.88M | Buy |
253,016
+5,839
| +2% | +$159K | ﹤0.01% | 2219 |
|
|
2024
Q1 | $8.98M | Sell |
247,177
-1,573
| -0.6% | -$57.2K | ﹤0.01% | 2101 |
|
|
2023
Q4 | $5.04M | Buy |
248,750
+37,460
| +18% | +$759K | ﹤0.01% | 2506 |
|
|
2023
Q3 | $3.75M | Buy |
211,290
+18,007
| +9% | +$320K | ﹤0.01% | 2608 |
|
|
2023
Q2 | $3.49M | Buy |
193,283
+41,917
| +28% | +$757K | ﹤0.01% | 2699 |
|
|
2023
Q1 | $1.9M | Sell |
151,366
-3,149
| -2% | -$39.6K | ﹤0.01% | 2962 |
|
|
2022
Q4 | $2.27M | Buy |
154,515
+4,732
| +3% | +$69.4K | ﹤0.01% | 2941 |
|
|
2022
Q3 | $2.56M | Buy |
149,783
+10,636
| +8% | +$182K | ﹤0.01% | 2881 |
|
|
2022
Q2 | $2.03M | Buy |
139,147
+70,415
| +102% | +$1.03M | ﹤0.01% | 3058 |
|
|
2022
Q1 | $1.16M | Sell |
68,732
-3,049
| -4% | -$51.3K | ﹤0.01% | 3359 |
|
|
2021
Q4 | $1.62M | Sell |
71,781
-2,230
| -3% | -$50.2K | ﹤0.01% | 3327 |
|
|
2021
Q3 | $1.6M | Sell |
74,011
-5,624
| -7% | -$121K | ﹤0.01% | 3386 |
|
|
2021
Q2 | $2.31M | Buy |
79,635
+12,600
| +19% | +$365K | ﹤0.01% | 3286 |
|
|
2021
Q1 | $2.16M | Sell |
67,035
-3,364
| -5% | -$108K | ﹤0.01% | 3200 |
|
|
2020
Q4 | $2.91M | Buy |
+70,399
| New | +$2.91M | ﹤0.01% | 2987 |
|